Pharmacist-founded. Fey is the AI procurement agent built from insight serving the 1,029 pharmacies already using Famasi, our pharmacy ERP, live across 47+ cities.
Pharmacies are the last-mile buyer in a $1.35T drug market, and they still buy by hand. Pharmacies on Fey save up to 15 hours a week and up to 30% in losses from manual buying and quote comparison.
Procurement is the largest unreformed cost in pharmacy. Pharmacists spend up to 15 hours a week calling wholesalers for quotes. Stockouts cost ~3% of revenue. Expiry write-offs consume 2 to 4% of inventory value annually. In a $1.35T drug market, that is billions in avoidable loss.
Fey runs semi-autonomous procurement: flagging stockouts before they happen, sending RFQs, comparing supplier quotes, placing orders against an approved policy, and reconciling deliveries against the PO. Pharmacies on Fey reclaim up to 30% of the losses driven by manual buying: stockouts, overstock, expiry write-offs, and the hours pharmacists spend buying instead of dispensing.
Systems of record tell pharmacies what left the shelf. Fey tells them what to order next.
1,029 pharmacies live on the infrastructure across 47+ cities. 6,500 in active pipeline via personal networks, pharmacy buying groups, and supplier partnerships.
RxSymphony, our integration layer, connects Fey to 20+ pharmacy management systems: Dispensary, TitanPMR, RxManager, PioneerRx, mSupply, even spreadsheets.
Over a decade experience in pharma supply chain, coordinating market entry and navigating regulatory hurdles. Previously built a digital pharmacy for chronic illnesses with an 85% refill rate, and established active relationships with pharmacies across 47+ cities.
McKesson, Cencora, and Cardinal Health control ~90% of US distribution. Their margins depend on the information asymmetry Fey eliminates. Supplier-agnostic recommendation is what pharmacies trust, and what makes a wholesaler acquisition self-defeating.
All Fortune 500 and general-enterprise focused. Pharmaceutical procurement is uncontested, and it is the lane where regulatory complexity, controlled-substance rules, and formulary constraints make the domain itself the moat.
A 20-branch enterprise chain on the same model: $50,160 ACV ($38,160 subscription + $12,000 commission on $2M drug spend at 60% routing). Subscription scales with branches. Commission scales with autonomy. Embedded finance origination becomes a third stream from the same data asset: procurement data underwrites inventory financing, working capital, and supplier terms. No new sales motion.
Regulatory compliance is designed into the architecture: Fey maintains audit logs for every procurement decision, supports controlled-substance ordering workflows per DEA requirements, and separates clinical recommendation from commercial execution.
10+ years Licensed Pharmacist
ex-mPharma (supply chain; $80M raised)
Market entry, Principle Vitamins (Europe's leading supplements brand)
Built digital pharmacy for chronic illnesses with 85% refill rate
13 years across media, product & growth
Built GTM at Clane (Zelle for Nigeria); designed B2G hospital bedspace utilisation
MPH Health Policy & Management; built modern ERP for 1,000+ pharmacies
Post-money SAFE on the standard YC form. $8M post-money cap.
Two ways forward, write founders@withfey.com: